Emerging Technologies

CHAI Develops AI Guidelines for Ethical Healthcare Innovation
Public Policy CHAI Develops AI Guidelines for Ethical Healthcare Innovation

In the rapidly evolving landscape of artificial intelligence, the healthcare sector faces the pressing challenge of leveraging AI technologies while ensuring ethical and responsible implementation. Despite the widespread integration of AI across healthcare systems, current regulations governing

Can AI Solve the Global Nursing Crisis?
Technology Can AI Solve the Global Nursing Crisis?

The world is experiencing a critical shortage of nurses, a problem that is only getting worse. According to projections, there will be a deficit of 4.5 million nurses by 2030, intensifying concerns about future healthcare delivery. Experts are increasingly looking at artificial intelligence (AI) as

Can Personalized AI Scribes Revolutionize Clinical Workflows?
Technology Can Personalized AI Scribes Revolutionize Clinical Workflows?

Imagine being a doctor with back-to-back patient appointments and a mountain of daily paperwork to complete, all while trying to maintain the quality of your medical practice. Now, consider the potential of a singular tool to revolutionize this daily grind: a personalized AI scribe. This

Revolutionizing Healthcare with Decentralized DAOs
Technology Revolutionizing Healthcare with Decentralized DAOs

In recent years, the healthcare industry has found itself at a crossroads, grappling with systemic inefficiencies, fragmented patient data systems, and a lack of transparency, all of which hinder effective service delivery. The complexity of patient data management, convoluted processes associated

How Are EMRs Transforming Healthcare in Indonesia?
Public Policy How Are EMRs Transforming Healthcare in Indonesia?

The digital revolution has firmly rooted itself in the global healthcare sector, and Indonesia stands out as a key player undergoing tremendous transformation with Electronic Medical Records (EMRs) at the forefront. As of today, the nation's healthcare system is embracing digitalization,

FDA Reviews Ziftomenib as Novel AML Therapy Targeting NPM1
Technology FDA Reviews Ziftomenib as Novel AML Therapy Targeting NPM1

Amidst growing challenges in treating acute myeloid leukemia (AML), the focus on genetic mutations has driven innovative therapies. One significant mutation in AML occurs in the nucleophosmin 1 (NPM1) gene, affecting about 30% of cases. The industry's push for targeted therapies to address

Loading

Subscribe to our weekly news digest

Keep up to date with the latest news and events

Paperplanes Paperplanes Paperplanes
Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later